Stoxx Europe 50
5.342,32
PKT
-32,36
PKT
-0,60
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.02.25 | ING Group Buy | UBS AG | |
| 06.02.25 | BNP Paribas Neutral | JP Morgan Chase & Co. | |
| 06.02.25 | TotalEnergies Buy | UBS AG | |
| 06.02.25 | Airbus Neutral | UBS AG | |
| 06.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Nestlé Neutral | UBS AG | |
| 06.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | Rio Tinto Neutral | UBS AG | |
| 06.02.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 06.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 06.02.25 | Santander Buy | UBS AG | |
| 06.02.25 | GSK Neutral | UBS AG | |
| 06.02.25 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
| 06.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 06.02.25 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | TotalEnergies Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | BNP Paribas Halten | DZ BANK | |
| 05.02.25 | Airbus Kaufen | DZ BANK | |
| 05.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | BNP Paribas Buy | Deutsche Bank AG | |
| 05.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 05.02.25 | GSK Outperform | Bernstein Research | |
| 05.02.25 | GSK Neutral | UBS AG | |
| 05.02.25 | TotalEnergies Outperform | RBC Capital Markets | |
| 05.02.25 | BAT Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | Intesa Sanpaolo Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Santander Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Zurich Insurance Hold | Deutsche Bank AG | |
| 05.02.25 | AXA Buy | Deutsche Bank AG | |
| 05.02.25 | Allianz Buy | Deutsche Bank AG | |
| 05.02.25 | TotalEnergies Buy | UBS AG | |
| 05.02.25 | LOréal Underweight | JP Morgan Chase & Co. | |
| 05.02.25 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.02.25 | Novo Nordisk Buy | UBS AG | |
| 05.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Santander Buy | UBS AG | |
| 05.02.25 | Novo Nordisk Underperform | Jefferies & Company Inc. |
